Pediatric Bipolar Disorder: The Promise of Psychopharmacotherapy

Tiffany Thomas, Robert L. Findling

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Pediatric bipolar disorder is a serious and chronic illness that can have debilitating effects on the lives of children and adolescents suffering from this disorder. Pharmacological therapy is a mainstay in the management of pediatric bipolar disorder. Until not too long ago, there was very little research of methodological rigor regarding the medication treatment of these vulnerable youngsters. However, over the past few years, clinical trials in the pharmacotherapy of pediatric bipolar disorder have been conducted and new data are emerging. These studies include the use of lithium, anticonvulsants/mood stabilizers, and atypical antipsychotics for the acute and long-term treatment of pediatric bipolar disorder. Despite these new advances, further placebo-controlled trials investigating the efficacy and safety (both acute and long-term) of pharmacologic interventions are still needed in this population.

Original languageEnglish (US)
Title of host publicationBipolar Psychopharmacotherapy
Subtitle of host publicationCaring for the Patient: Second Edition
PublisherJohn Wiley and Sons
Pages351-367
Number of pages17
ISBN (Print)9780470747216
DOIs
StatePublished - Apr 13 2011

    Fingerprint

Keywords

  • Acute treatment
  • Adolescents
  • Anticonvulsants
  • Atypical antipsychotics
  • Children
  • Lithium
  • Maintenance treatment
  • Mood stabilizers
  • Pediatric bipolar disorder
  • Pharmacotherapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Thomas, T., & Findling, R. L. (2011). Pediatric Bipolar Disorder: The Promise of Psychopharmacotherapy. In Bipolar Psychopharmacotherapy: Caring for the Patient: Second Edition (pp. 351-367). John Wiley and Sons. https://doi.org/10.1002/9780470975114.ch17